SCHEMBL31099434

SCHEMBL31099434

CCCCCCCCSc1nc(Nc2ccccc2O)nc(SCCCCCCCC)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 2/20 0.44
▸ CDK2 P24941 2/20 0.44
▸ EPHX2 P34913 1/20 0.40
▸ PPARG P37231 1/20 0.40
▸ GAA P10253 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PLK1 P53350 1/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ ADORA1 P30542 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1271004 1.00 CCNE1 (0.44) CCNE1CDK2EPHX2PPARGGAA
SCHEMBL11805831 0.83 CCNE1 (0.46) CCNE1CDK2PPARGGAAMAPT
SCHEMBL11808183 0.83 CCNE1 (0.46) CCNE1CDK2PPARGGAAMAPT
SCHEMBL15488498 0.81 CCNE1 (0.38) CCNE1CDK2PPARGMAPTPLK1
SCHEMBL19327103 0.79 TP53 (0.36) CCNE1CDK2PPARGMAPTMAPK1
SCHEMBL1271005 0.78 CCNE1 (0.44) CCNE1CDK2MAPTCYP3A4MAPK1
SCHEMBL30427808 0.77 TP53 (0.37) CCNE1CDK2PPARGMAPTMAPK1
SCHEMBL2043321 0.77 GPR84 (0.35) CCNE1CDK2PPARGMAPTCYP1A2
SCHEMBL19327155 0.77 CCNE1 (0.34) CCNE1CDK2PPARGMAPTMAPK1
SCHEMBL31252527 0.76 CCNE1 (0.37) CCNE1CDK2PPARGMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606693-B2 Method of storing antioxidant mixture SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-04-21 — — US disclosed
EP-4477726-A1 METHOD OF STORING ANTIOXIDANT MIXTURE Sumitomo Chemical Company, Limited (JP) 2024-12-18 — — EP disclosed
EP-4474447-A2 ANTIOXIDANT MIXTURE Sumitomo Chemical Company, Limited (JP) 2024-12-11 — — EP disclosed
US-20240301100-A1 METHOD FOR PRODUCING HETEROPHASIC PROPYLENE POLYMERIZATION MATERIAL AND METHOD FOR PRODUCING OLEFIN POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-09-12 — — US disclosed
US-20240294735-A1 METHOD OF STORING ANTIOXIDANT MIXTURE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-09-05 — — US disclosed
US-20240287283-A1 METHOD OF STORING ANTIOXIDANT MIXTURE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-08-29 — — US disclosed
EP-4421149-A2 METHOD OF STORING ANTIOXIDANT MIXTURE Sumitomo Chemical Company, Limited (JP) 2024-08-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12606693-B2 Method of storing antioxidant mixture GPX1, SOD1, ACSL3 CCNE1 2316/4885CDK2 3802/4885EPHX2 1676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback